Cadmium, a metallic inhibitor of antibody-mediated immunity in mice.
Chronic administration of cadmium chloride to B10-A-2R mice was discovered to severely depress the numbers and to delay the onset of appearance of splenic IgG and IgM plaque-forming cells (PFC) following injection of sheep erythrocytes. A recovery period of at least 1 month following cessation of administration of CdCl2 resulted in no increase in IgM PFC and only a minimal increase in IgG PFC. An apparent cadmium-induced splenomegaly was also noted in the intoxicated mice. Application of immune adherence and rosetting techniques as well as immunofluorescence to study the cellular morphology of these spleens indicated that the cell type most responsible for the increased spleen size had Fc and complement receptors as well as surface or cytoplasmic immunoglobulins. Populations of polymorphs and macrophages were not found to significantly contribute to the hyperplasia observed.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002104:Cadmium / Q000008:administration & dosage / Q000494:pharmacology*; D004306:Dose-Response Relationship, Immunologic; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D007109:Immunity / Q000187:drug effects*; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D051379:Mice; D012397:Rosette Formation; D013154:Spleen / Q000276:immunology*; D013194:Staining and Labeling
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D002104:Cadmium